Results of Base-Case Analysis In unscreened elderly with no, moderate, and severe comorbidity, CRC screening was cost-effective up to age 86, 83, and 80, respectively. In unscreened elderly with no comorbidity, colonoscopy screening was most effective and still cost-effective up to age 83; sigmoidoscopy screening was indicated at age 84; and FIT screening was indicated at ages 85 and 86. In unscreened elderly with moderate (severe) comorbidity, colonoscopy screening was indicated up to age 80 (77); sigmoidoscopy screening was indicated at age 81 (78); and FIT screening was indicated at ages 82 and 83 (79 and 80). 